CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Stifel Initiates Lyell Immunopharma at Buy With $36 Price Target

Positive
AI Analysis

Summary

Stifel initiated coverage of Lyell Immunopharma with a Buy rating and $36 price target. This is a routine analyst initiation with no material clinical, regulatory, or financial catalyst.

Importance:2/10
Sentiment:
0.60
analyst_initiationprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 6, 2026 11:18 AM

Read Original